help button home button Endocrine Society Molecular Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on November 30, 2006
Molecular Endocrinology, doi:10.1210/me.2006-0337
A more recent version of this article appeared on February 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
21/2/359    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boonyaratanakornkit, V.
Right arrow Articles by Edwards, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boonyaratanakornkit, V.
Right arrow Articles by Edwards, D. P.

Submitted on August 15, 2006
Accepted on November 21, 2006

The Role of Extra-nuclear Signaling Actions of Progesterone Receptor in Mediating Progesterone Regulation of Gene Expression and the Cell Cycle

Viroj Boonyaratanakornkit, Eileen McGowan, Lori Sherman, Michael A. Mancini, Boris J. Cheskis, and Dean P. Edwards*

Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030 ; Garvan Institute of Medical Research, Cancer Research Program, Darlinghurst NSW, 2010, Australia , University of Colorado Health Sciences Center Cancer Center, Aurora, CO 80045 , Wyeth Womens Health Research Institute, Collegeville, PA 19426

* To whom correspondence should be addressed. E-mail: deane{at}bcm.tmc.edu.

Human progesterone receptor (PR) contains a motif that interacts with the SH3 domain of Src and mediates rapid activation of Src and down stream MAP kinase (Erk-1/-2) without relying on the transcriptional activity of the receptor. Here we investigated the role and intracellular location of this non-transcriptional activity of PR. Progestin activation of Src/MAPK occurred outside the nucleus with the B isoform of PR that was distributed between the cytoplasm and nucleus, but not with PR-A that was predominantly nuclear. Breast cancer cells stably expressing wild type PR-B or PR-B with disrupting point mutations in the SH3 domain binding motif (PR-B{Delta}SH3) that do not affect the transcriptional activity of PR, were compared for effects of progestin on endogenous target gene expression and cell proliferation. Progestin induction of the cyclin D1 gene, that lacks a progesterone response element (PRE), was dependent on PR activation of the Src/MAPK pathway whereas induction of the Sgk (serum and glucocorticoid regulated kinase) gene that contains a functional PRE was unaffected by mutations that interfere with PR activation of Src. Progestin induction of cell cycle progression was also abrogated in cells expressing PR-B{Delta}SH3, and no effect of progestin on cyclin D1 expression and cell cycle was observed in the presence of PR-A. These results highlight the importance of PR activation of the Src/MAPK signaling pathway for progesterone induced transcription of select target genes and cell cycle progression.


Key words: progesterone receptor • Src tyrosine kinase • cyclin D1 • cell cycle • gene regulation

NURSA Molecule Pages Link:

Nuclear Receptors:   PR
Ligands:   R5020



This article has been cited by other articles:


Home page
Endocr Relat CancerHome page
P. de Cremoux, D. Rosenberg, J. Goussard, C. Bremont-Weil, F. Tissier, C. Tran-Perennou, L. Groussin, X. Bertagna, J. Bertherat, and M.-L. Raffin-Sanson
Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease
Endocr. Relat. Cancer, June 1, 2008; 15(2): 465 - 474.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
F. Nuttinck, B. M.-L. Guienne, L. Clement, P. Reinaud, G. Charpigny, and B. Grimard
Expression of genes involved in prostaglandin E2 and progesterone production in bovine cumulus-oocyte complexes during in vitro maturation and fertilization
Reproduction, May 1, 2008; 135(5): 593 - 603.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
E. J. Faivre, A. R. Daniel, C. J. Hillard, and C. A. Lange
Progesterone Receptor Rapid Signaling Mediates Serine 345 Phosphorylation and Tethering to Specificity Protein 1 Transcription Factors
Mol. Endocrinol., April 1, 2008; 22(4): 823 - 837.
[Abstract] [Full Text] [PDF]


Home page
J ANIM SCIHome page
F. Stormshak and C. V. Bishop
BOARD-INVITED REVIEW: Estrogen and progesterone signaling: Genomic and nongenomic actions in domestic ruminants
J Anim Sci, February 1, 2008; 86(2): 299 - 315.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
N. Chen and J. L. Napoli
All-trans-retinoic acid stimulates translation and induces spine formation in hippocampal neurons through a membrane-associated RAR{alpha}
FASEB J, January 1, 2008; 22(1): 236 - 245.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. R. Hammes and E. R. Levin
Extranuclear Steroid Receptors: Nature and Actions
Endocr. Rev., December 1, 2007; 28(7): 726 - 741.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
A. R. Daniel, E. J. Faivre, and C. A. Lange
Phosphorylation-Dependent Antagonism of Sumoylation Derepresses Progesterone Receptor Action in Breast Cancer Cells
Mol. Endocrinol., December 1, 2007; 21(12): 2890 - 2906.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Feroze-Zaidi, L. Fusi, M. Takano, J. Higham, M. S. Salker, T. Goto, S. Edassery, K. Klingel, K. M. Boini, M. Palmada, et al.
Role and Regulation of the Serum- and Glucocorticoid-Regulated Kinase 1 in Fertile and Infertile Human Endometrium
Endocrinology, October 1, 2007; 148(10): 5020 - 5029.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
E. M. McGowan, A. J. Russell, V. Boonyaratanakornkit, D. N. Saunders, G. M. Lehrbach, C. M. Sergio, E. A. Musgrove, D. P. Edwards, and R. L. Sutherland
Progestins Reinitiate Cell Cycle Progression in Antiestrogen-Arrested Breast Cancer Cells through the B-Isoform of Progesterone Receptor
Cancer Res., September 15, 2007; 67(18): 8942 - 8951.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
K. P. Madauss, E. T. Grygielko, S.-J. Deng, A. C. Sulpizio, T. B. Stanley, C. Wu, S. A. Short, S. K. Thompson, E. L. Stewart, N. J. Laping, et al.
A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator
Mol. Endocrinol., May 1, 2007; 21(5): 1066 - 1081.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2006 by The Endocrine Society